Nasal gene therapy offers new hope for brain injury patients
NCT ID NCT07264166
First seen Jan 04, 2026 · Last updated May 20, 2026 · Updated 19 times
Summary
This study follows 25 people aged 2 to 65 with chronic brain damage from lack of oxygen (HIE) who receive an experimental gene therapy through the nose. The therapy delivers 15 genes meant to repair brain cells, reduce inflammation, and improve movement and thinking. Researchers will track changes in motor skills, cognition, and quality of life over 12 months to see if the therapy helps.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL PALSY (CP) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Stem Solutions
Monterrey, Nuevo León, 64000, Mexico
Conditions
Explore the condition pages connected to this study.